Related Experiment Video
Updated: Jul 30, 2026

09:39
Creation of Reversible Cholestatic Rat Model
Published on: May 21, 2011
Cholestasis and alcoholic liver disease
1Department of Medicine, Division of Gastroenterology, Section of Hepatology, University of Washington School of Medicine, Seattle, Washington, USA.
Clinics in Liver Disease
|April 9, 2001
Summary
Alcoholic liver disease can cause jaundice and cholestasis, sometimes without other typical signs. Differentiating it from other conditions may require invasive tests, with risks depending on liver function.
Area of Science:
- Hepatology
- Gastroenterology
- Toxicology
Background:
- Alcoholic liver disease encompasses various stages, often presenting with histologic cholestasis and clinical jaundice.
- Rarely, alcoholic patients exhibit isolated cholestasis without significant steatosis, hepatitis, or cirrhosis.
- The precise mechanisms of ethanol-induced cholestasis remain incompletely understood.
Purpose of the Study:
- To summarize the presentation and diagnostic considerations of cholestasis in alcoholic liver disease.
- To discuss the differential diagnosis between alcohol-induced cholestasis and extrahepatic biliary obstruction.
- To highlight the role and risks of invasive diagnostic procedures.
Main Methods:
- Review of clinical, biochemical, and radiologic data for differentiating causes of jaundice in alcoholic patients.
- Consideration of invasive diagnostic modalities when non-invasive methods are insufficient.
- Assessment of risks associated with liver biopsy and ERCP in patients with hepatic dysfunction.
Main Results:
- Cholestasis and jaundice are common in alcoholic liver disease but can occur in isolation.
- Clinical, biochemical, and radiologic findings often suffice to distinguish alcohol-induced liver disease from biliary obstruction.
- In ambiguous cases, liver biopsy or ERCP may be required, with procedural risks correlating with liver dysfunction severity.
Conclusions:
- Cholestasis is a key feature of alcoholic liver disease, with varied presentations.
- Accurate diagnosis relies on a combination of clinical assessment and diagnostic imaging.
- Invasive procedures should be carefully considered due to potential risks in patients with compromised liver function.
Related Concept Videos
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

